GPFM 09A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon

Cancer Research

Volumn 69, Issue 7, 2009, Pages 2826-2832

  Thangaraju, Muthusamy ^a   Cresci, Gail A ^a   Liu, Kebin ^a   Ananth, Sudha ^a   Gnanaprakasam, Jaya P ^a   Browning, Darren D ^a   Mellinger, John D ^a   Smith, Sylvia B ^a   Digby, Gregory J ^a   Lambert, Nevin A ^a   Prasad, Puttur D ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLIN D1; DEATH RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINIC ACID; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; GPR109A PROTEIN, HUMAN; GPR109B PROTEIN, MOUSE; MESSENGER RNA; NICOTINIC RECEPTOR;

ANIMAL TISSUE; APICAL MEMBRANE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DEACETYLATION; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; FERMENTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL STRAIN HCT116; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BUTYRATES; COLON; COLONIC NEOPLASMS; DNA METHYLATION; FERMENTATION; GENE SILENCING; HCT116 CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NIACIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; RNA, MESSENGER; TRANSFECTION;

EID: 66149084058     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4466     Document Type: Article

References (40)

1. Hooper LV Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-18.
2. Backhed F1 Ley RE, Sonnehburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005;307:1915-1920.
3. Turribaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
4. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: rdes of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031-64.
5. Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. ScandJ Gastroenterol 1996;216:132-148
6. Manning TS, Gibson GR. Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol 2004;18:287-98.
7. Wong JM, de Souza R, Kendall CW, Emam. A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006:40:235-243
8. World Cancer Research Fund and American. Institute for Cancer Research. Patterns of diet and cancer. In: Potter JD, editor. Food, nutrition, and prevention of cancer: a global, perspective. Washington. (DC): American. Institute for Cancer Research; 1997. p. 20-52.
9. Scheppach W, Weller F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 2004;7: 563-67.
10. Marks P, Rifkind RA, Richon VM1 et al. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001;1:194-202.
11. Drummond DC, Noble CO, Kirpotin. DB, et al. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 2005; 45:495-528.
12. Miyauchi S1 Gopal E1 FeI YJ1 Ganapathy V. Functional identification of SLC5A8, a tumor suppressor down- regulated in colon, cancer, as a Na+-coupled transporter for short-chain fatty adds. J Biol Chem 2004;279:13293-6.
13. Coady MJ, Chang MH, Charron FM, et al. The tumor suppressor gene SLC5A8 expresses a Na+-monocarbox- ylate cotransporter. J Physiol 2004;557:719-31.
14. Gopal E, FeI YJ, Sugawara M, et al. Expression of slcSaS in kidney and its role In Na+-coupled transport of lactate. J Bid Chem 2004;279:44522-32.
15. Gopal E, Fel YJ, Miyauchi S, et al. Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. Biochem J 2005:388: 309-16.
16. Martin PM, Gopal E, Ananth S, et al. Identity of SMCTl. (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain. J Neurochem 2006:98:279-88.
17. Gopal. E, Miyauchi S, Martin PM, et al. Transport of nicotinate and structurally related compounds by human SMCTl (S.LC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm Res 2007;24:575-84.
18. Li H1 Myeroff L1 Smiraglia D1 et al. S.LC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human, colon, aberrant crypt foci and cancers. Proc Natl Acad Sd U S A 2003;100:8412-17.
19. Paroder V, Spencer SR, Parader M, et al. Na+/ monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization, of SMCT. Proc Natl Acad Sd U S A 2006;103:7270-75.
20. Thangaraju M, Cresci G, Itagaki S, et al. Sodium- coupled transport of the short-chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 2008;12:1773-82.
21. Ganapathy V, Gopal. E, Miyauchi S, Prasad PD. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem Soc Trans 2005;33:237-240
22. Gupta N, Martin PM, Prasad PD, Ganapathy V. S.LC5A8 (SMCTl.)-mediated transport of butyrate forms the basis for the tumor suppressive function, of the transporter. Life Sei 2006:78:2419-25.
23. Ganapathy V, Thangaraju M, Gopal. E, et al. Sodium- coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J 2008;10:193-199
24. Takebe K, Nio J, Morim atsu M, et al. Histochemical. demonstration of a Na"-coupled transporter for short- chain fatty adds (slcSaS) in. the intestine and kidney of the mouse. Biomed Res 2005;26:213-21.
25. Soga T, Kamohara M, Takasaki J, et al. Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun 2003:303:364-369
26. Wise A, Foord SM1 Fraser NJ1 et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003:278:9869-9874
27. Tunaru S, Kero J1 Schaub A, et al. PUMA-G and H.M74 are receptors for nicotinic acid and mediate its anti- lipolytlc effect. Nat Med 2003;9:352-5.
28. Taggart AK, Kero J, Gan X, et al. (D)-ß-Hydraxybu- tyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005;280:26649-52.
29. Hamer HM1 Jonkers D, Venema K1 Vanhoutvin S1 Troost FJ1 Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008;27:104-19.
30. Gille A1 Bodor ET1 Ahmed K1 Offermanns S. Nicotinic acid: pharmacological effects and mechanisms of action. Annu Rev Pharmacol Toxicol 2008:48:79-106.
31. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, Ganapathy V. Molecular and ligand-binding char- acterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 1999:289: 251-60.
32. Digby GJ, Sethi PR, Lambert NA. Differential dissociation of G protein heterotrimers. J Physiol 2008; 586:3325-3335
33. Gupta N, Miyauchi. S, Martindale RG, et al. Up- regulation. of the amino acid transporter ATB '* (SLC6A1.4) in colorectal cancer and metastasis in. humans. Biochim Biophys Acta 2005:1741:215-223
34. Thangaraju M, Carswell KN, Prasad PD, Ganapathy V. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDACI/HDAC3. Biochem. J 2009;417:379-89.
35. Logothetis DE, Kurachi Y, Galper J, Neer EJ, Clapham DE. The B γ subunits of GTP-bindlng proteins activate the muscarinic K+ channel in heart. Nature 1987:325:321-6.
36. Lee BH, Yegnasubramanian S, Lin X, Nelson. WG. Procainamide is a specific inhibitor of DNA methyl- transferase 1. J Biol Chem 2005;280:40749-56.
37. Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem 2007;76: 141-65.
38. Goffin J, Eisenhauer E. DNA methyltransferase Inhibitors-state of the art. Ann Oncol 2002; 13: 1699-716.
39. Karin M. Nuclear factor-KB in cancer development and progression. Nature 2006;441:431-436
40. Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N1 Pace NR. Molecular-phylogenetic character- ization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sei USA 2007;104:13780-85.